My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 281

    1.

    RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.

    Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H.

    Diabetes. 2006 Sep;55(9):2510-22.PMID: 16936199 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

    Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H.

    J Clin Invest. 2001 Jul;108(2):261-8.PMID: 11457879 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.

    Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM.

    Am J Pathol. 2003 Apr;162(4):1123-37.PMID: 12651605 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

    Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD.

    J Am Soc Nephrol. 2000 Sep;11(9):1656-66.PMID: 10966490 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

    Wendt T, Tanji N, Guo J, Hudson BI, Bierhaus A, Ramasamy R, Arnold B, Nawroth PP, Yan SF, D'Agati V, Schmidt AM.

    J Am Soc Nephrol. 2003 May;14(5):1383-95. Review.PMID: 12707408 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.

    He CJ, Zheng F, Stitt A, Striker L, Hattori M, Vlassara H.

    Kidney Int. 2000 Nov;58(5):1931-40.PMID: 11044213 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.

    Suzuki D, Toyoda M, Yamamoto N, Miyauchi M, Katoh M, Kimura M, Maruyama M, Honma M, Umezono T, Yagame M.

    Intern Med. 2006;45(7):435-41. Epub 2006 May 1.PMID: 16679697 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Receptor for advanced glycation end products is a promising target of diabetic nephropathy.

    Yamamoto Y, Doi T, Kato I, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Myint KM, Harashima A, Takeuchi M, Takasawa S, Okamoto H, Hashimoto N, Asano M, Yamamoto H.

    Ann N Y Acad Sci. 2005 Jun;1043:562-6.PMID: 16037279 [PubMed - indexed for MEDLINE]Related articles

    9.

    Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

    Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

    J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice.

    Inagi R, Yamamoto Y, Nangaku M, Usuda N, Okamato H, Kurokawa K, van Ypersele de Strihou C, Yamamoto H, Miyata T.

    Diabetes. 2006 Feb;55(2):356-66.PMID: 16443768 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.

    Inagi R, Nangaku M, Miyata T.

    Ann N Y Acad Sci. 2005 Jun;1043:605-8. Review.PMID: 16037283 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.

    Huang Y, Lin S, Zhou J.

    Chin Med J (Engl). 1998 Aug;111(8):698-704.PMID: 11245022 [PubMed - indexed for MEDLINE]Related articles

    13.

    RAGE mRNA expression in the diabetic mouse kidney.

    Ziyadeh FN, Cohen MP, Guo J, Jin Y.

    Mol Cell Biochem. 1997 May;170(1-2):147-52.PMID: 9144329 [PubMed - indexed for MEDLINE]Related articles

    14.

    Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

    Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y.

    Nephrol Dial Transplant. 2004 Dec;19(12):3012-20.PMID: 15574998 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    RAGE: a novel target for drug intervention in diabetic vascular disease.

    Hudson BI, Schmidt AM.

    Pharm Res. 2004 Jul;21(7):1079-86. Review.PMID: 15290845 [PubMed - indexed for MEDLINE]Related articles

    16.

    Novel inhibitors of glycation and AGE formation.

    Rahbar S.

    Cell Biochem Biophys. 2007;48(2-3):147-57.PMID: 17709884 [PubMed - indexed for MEDLINE]Related articles

    17.

    RAGE in diabetic nephropathy.

    Yamamoto H, Watanabe T, Yamamoto Y, Yonekura H, Munesue S, Harashima A, Ooe K, Hossain S, Saito H, Murakami N.

    Curr Mol Med. 2007 Dec;7(8):752-7. Review.PMID: 18331233 [PubMed - indexed for MEDLINE]Related articles

    18.

    Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.

    Xu L, Li B, Cheng M, Zhang W, Pan J, Zhang C, Gao H.

    Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):215-24. Epub 2008 Feb 2.PMID: 18273752 [PubMed - indexed for MEDLINE]Related articles

    19.

    Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

    Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME.

    J Clin Invest. 2001 Dec;108(12):1853-63.PMID: 11748269 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The AGE-RAGE system and diabetic nephropathy.

    Sakurai S, Yonekura H, Yamamoto Y, Watanabe T, Tanaka N, Li H, Rahman AK, Myint KM, Kim CH, Yamamoto H.

    J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S259-63. Review.PMID: 12874443 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity